首页> 外文期刊>International Hatchery Practice >Celebrating a major advancement for the poultry industry science
【24h】

Celebrating a major advancement for the poultry industry science

机译:庆祝家禽业和科学的重大进步

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This year marks a 30-year milestone in commercialised in ovo vaccination technology, first introduced by Embrex in 1992. While in ovo vaccination is standard practice for many hatcheries today, this important process was considered an impossibility not too long ago.In its simplest terms, in ovo vaccination delivers vaccine to the chick before hatching to stimulate an immune response that helps protect them from disease at hatch. The technology was originally developed to help combat early Marek’s disease challenges in flocks.
机译:今年是Embrex于1992年首次推出的卵巢疫苗接种技术商业化的30年里程碑。虽然卵子疫苗接种是当今许多孵化场的标准做法,但不久前这一重要过程还被认为是不可能的。简单来说,卵疫苗接种在孵化前将疫苗输送给雏鸡,以刺激免疫反应,帮助它们在孵化时保护它们免受疾病侵害。该技术最初是为了帮助应对鸡群中的早期马立克氏病挑战而开发的。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号